Adcock Ingram Holdings (JSE:AIP) 5-Year EBITDA Growth Rate : 6.90% (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Adcock Ingram Holdings 5-Year EBITDA Growth Rate?

Adcock Ingram Holdings's EBITDA per Share for the six months ended in Dec. 2023 was R4.15.

During the past 12 months, Adcock Ingram Holdings's average EBITDA Per Share Growth Rate was 5.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 16.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 6.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Adcock Ingram Holdings was 16.20% per year. The lowest was -11.60% per year. And the median was 1.25% per year.

Competitive Comparison of Adcock Ingram Holdings's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Adcock Ingram Holdings's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adcock Ingram Holdings's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adcock Ingram Holdings's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Adcock Ingram Holdings's 5-Year EBITDA Growth Rate falls into.

Adcock Ingram Holdings 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Adcock Ingram Holdings (JSE:AIP) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Adcock Ingram Holdings 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Adcock Ingram Holdings's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Adcock Ingram Holdings (JSE:AIP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adcock Ingram Holdings Ltd (JSE:AIP) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 New Road, (c/o New Road & 7th Street), Midrand, Johannesburg, GT, ZAF, 1682

Website

https://www.adcock.com

Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company generates roughly two-thirds of its sales from the private sector, with the remaining from the public sector. Adcock operates in four broad areas: renal disease, medicine delivery, transfusion therapies, and blood and specialized pharmaceuticals. The company generates the vast majority of its revenue in southern Africa, followed by the rest of Africa and India.